IDEAS home Printed from https://ideas.repec.org/a/abf/journl/v52y2023i4p43952-43956.html

Can Digital Technology Change the Face of Clinical Trials? A Narrative Review

Author

Listed:
  • Jaquellyne Gurgel Penaforte-Saboia

    (Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Ceará, Brazil)

Abstract

Randomized clinical trials (RCTs) are the gold-standard method for clinical research. However, major intrinsic challenges to their conduct exist, such as elevated costs, long duration, and difficulty in recruiting. Digital Technology (DT) can provide innovative solutions to overcome these challenges. The aim of this review is to critically evaluate its use in clinical research.

Suggested Citation

  • Jaquellyne Gurgel Penaforte-Saboia, 2023. "Can Digital Technology Change the Face of Clinical Trials? A Narrative Review," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 52(4), pages 43952-43956, August.
    • Handle: RePEc:abf:journl:v:52:y:2023:i:4:p:43952-43956
    DOI: 10.26717/BJSTR.2023.52.008289
    as

    Download full text from publisher

    File URL: https://biomedres.us/pdfs/BJSTR.MS.ID.008289.pdf
    Download Restriction: no
    File URL: https://biomedres.us/fulltexts/BJSTR.MS.ID.008289.php
    Download Restriction: no
    File URL: https://libkey.io/10.26717/BJSTR.2023.52.008289?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. repec:plo:pone00:0107374 is not listed on IDEAS
    2. Sam S Oh & Joshua Galanter & Neeta Thakur & Maria Pino-Yanes & Nicolas E Barcelo & Marquitta J White & Danielle M de Bruin & Ruth M Greenblatt & Kirsten Bibbins-Domingo & Alan H B Wu & Luisa N Borrell, 2015. "Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled," PLOS Medicine, Public Library of Science, vol. 12(12), pages 1-9, December.
    3. Sarah J Iribarren & Kenrick Cato & Louise Falzon & Patricia W Stone, 2017. "What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-20, February.
    4. DiMasi, Joseph A. & Grabowski, Henry G. & Hansen, Ronald W., 2016. "Innovation in the pharmaceutical industry: New estimates of R&D costs," Journal of Health Economics, Elsevier, vol. 47(C), pages 20-33.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Secinaro, Silvana & Brescia, Valerio & Lanzalonga, Federico & Santoro, Gabriele, 2022. "Smart city reporting: A bibliometric and structured literature review analysis to identify technological opportunities and challenges for sustainable development," Journal of Business Research, Elsevier, vol. 149(C), pages 296-313.
    2. Dosis, Anastasios & Muthoo, Abhinay, 2019. "Experimentation in Dynamic R&D Competition," CRETA Online Discussion Paper Series 52, Centre for Research in Economic Theory and its Applications CRETA.
    3. Yusuke Oh & Koji Takahashi, 2020. "R&D and Innovation: Evidence from Patent Data," Bank of Japan Working Paper Series 20-E-7, Bank of Japan.
    4. Gamba, Simona & Magazzini, Laura & Pertile, Paolo, 2021. "R&D and market size: Who benefits from orphan drug legislation?," Journal of Health Economics, Elsevier, vol. 80(C).
    5. Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022. "Generic competition and the incentives for early-stage pharmaceutical innovation," Research Policy, Elsevier, vol. 51(10).
    6. Mary D Adu & Usman H Malabu & Aduli E O Malau-Aduli & Bunmi S Malau-Aduli, 2019. "Enablers and barriers to effective diabetes self-management: A multi-national investigation," PLOS ONE, Public Library of Science, vol. 14(6), pages 1-22, June.
    7. Miozza, Mario & Lombardo, Salvatore M. & Galvagno, Marco & Magni, Luca, 2026. "Bridging the digital divide in the pharmaceutical industry: A future research agenda," Social Science & Medicine, Elsevier, vol. 389(C).
    8. Sam Peltzman, 2022. "“The theory of economic regulation” after 50 years," Public Choice, Springer, vol. 193(1), pages 7-21, October.
    9. Unsal, Omer & Houston, Reza, 2024. "R&D grants and medical innovation," Journal of Economics and Business, Elsevier, vol. 128(C).
    10. Stacciarini, João Henrique Santana, 2025. "Investigación y Desarrollo (I+D) en el Sector Farmacéutico: avances, limitaciones, selectividad y negligencia," SocArXiv vbxzs, Center for Open Science.
    11. Bae, Joonhyung & Ozmel, Umit, 2024. "The interplay between product development failures and alliance portfolio properties in the formation of exploration versus exploitation alliances," Journal of Business Research, Elsevier, vol. 177(C).
    12. Abe C. Dunn & Lasanthi Fernando & Eli Liebman, 2024. "How Much Are Medical Innovations Worth? A Detailed Analysis Using Cost-Effectiveness Studies," BEA Papers 0132, Bureau of Economic Analysis.
    13. Alfred B. Ordman, 2022. "When Will the FDA Do What Is in People’s Best Interests?," American Journal of Economics and Sociology, Wiley Blackwell, vol. 81(4), pages 721-751, September.
    14. Edouard Debonneuil & Anne Eyraud-Loisel & Frédéric Planchet, 2018. "Can Pension Funds Partially Manage Longevity Risk by Investing in a Longevity Megafund?," Risks, MDPI, vol. 6(3), pages 1-27, July.
    15. Thakur-Wernz, Pooja & Bruyaka, Olga & Contractor, Farok, 2020. "Antecedents and relative performance of sourcing choices for new product development projects," Technovation, Elsevier, vol. 90.
    16. Li, Yajing & Garg, Sam, 2025. "Balancing power: The role of independent directors on venture boards," Journal of Business Venturing, Elsevier, vol. 40(4).
    17. Billette de Villemeur, Etienne & Versaevel, Bruno, 2019. "One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry," Journal of Health Economics, Elsevier, vol. 65(C), pages 260-283.
    18. Joshua Krieger & Danielle Li & Dimitris Papanikolaou, 2022. "Missing Novelty in Drug Development," The Review of Financial Studies, Society for Financial Studies, vol. 35(2), pages 636-679.
    19. Helena Biancuzzi & Francesca Dal Mas & Chiara Bidoli & Veronica Pegoraro & Maristella Zantedeschi & Pietro Antonio Negro & Stefano Campostrini & Lorenzo Cobianchi, 2023. "Economic and Performance Evaluation of E-Health before and after the Pandemic Era: A Literature Review and Future Perspectives," IJERPH, MDPI, vol. 20(5), pages 1-18, February.
    20. Maya M. Durvasula & Sabri Eyuboglu & David M. Ritzwoller, 2024. "Counting Clinical Trials: New Evidence on Pharmaceutical Sector Productivity," Papers 2405.08030, arXiv.org, revised Jan 2025.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;

    JEL classification:

    • R00 - Urban, Rural, Regional, Real Estate, and Transportation Economics - - General - - - General
    • Z0 - Other Special Topics - - General

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:abf:journl:v:52:y:2023:i:4:p:43952-43956. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Angela Roy (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.